TP53 and glioblastoma: Specifically, Golding et al. reported that ATM inhibition by KU-60019 hindered the phosphorylation of TRIM28, alongside p53 and H2AX, affecting DNA damage pathways and leading to enhanced radiosensitivity in glioblastoma cell lines [99].